Jay R. Luly's Net Worth

$28.3 Million

Estimate Recalculated Jul 15, 2024 04:30PM EST

Who is Jay R. Luly?

Jay R. Luly has an estimated net worth of $28.3 Million. This is based on reported shares in ENANTA PHARMACEUTICALS INC.

SEC CIK

Jay R. Luly's CIK is 0001571211

Past Insider Trading and Trends

2016 was Jay R. Luly's most active year for acquiring shares with 8 total transactions. Jay R. Luly's most active month to acquire stocks was the month of October. 2014 was Jay R. Luly's most active year for disposing of shares, totalling 18 transactions. Jay R. Luly's most active month to dispose stocks was the month of November. 2022 saw Jay R. Luly paying a total of $941,258.33 for 259,591 shares, this is the most they've acquired in one year. In 2019 Jay R. Luly cashed out on 38,612 shares for a total of $2,055,202.80, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ENANTA PHARMACEUTICALS INC (ENTA) Snapshot price: $12.225

President and CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+0.47%
3.82K
$12.41
-$19,657.44
810.61K
Feb 12
Form 4
-0.89%
-7.23K
$9.63
-$69,624.90
806.79K
Dec 5
Form 4
-0.71%
-5.79K
$9.49
-$54,918.63
814.02K
Dec 1
Form 4
—
0
—
—
0
Nov 22
Form 4
—
0
$29.58
-$869,860.34
819.81K
Scheduled
Mar 13
Form 4/A
+4.00%
31.5K
$52.77
-$1,086,587.07
819.81K
Feb 13
Form 4
+1.38%
10.91K
$52.77
-$1,086,587.07
799.22K
Feb 13
Form 4
+1.87%
14.5K
$27.58
$399,910.00
788.3K
Dec 19
Form 4
—
0
$29.41
-$918,806.03
773.8K
Scheduled
Dec 16
Form 4
-0.73%
-5.66K
$44.33
-$250,863.47
773.8K
Dec 1
Form 4
+8.79%
63K
—
—
779.46K
Nov 23
Form 4
+0.80%
5.67K
$62.49
-$147,163.95
716.46K
Feb 14
Form 4
+1.44%
10.06K
$11.77
$118,441.51
710.79K
Jan 15
Form 4
-0.28%
-1.94K
$87.68
-$170,449.92
700.73K
Dec 1
Form 4
+3.80%
25.7K
—
—
702.67K
Nov 19
Form 4
-0.66%
-4.52K
$59.06
-$266,697.80
676.97K
Scheduled
Sep 15
Form 4
+0.78%
5.3K
$42.52
-$93,586.52
681.49K
Dec 15
Form 4
+4.08%
26.5K
—
—
676.19K
Nov 20
Form 4
+1.13%
7.27K
$52.76
-$164,716.72
649.69K
Feb 12
Form 4
+0.65%
4.17K
$63.88
-$212,720.40
642.42K
Dec 16
Form 4
—
0
—
—
0
Nov 18
Form 4
+1.12%
7.05K
$14.18
$99,997.36
638.25K
Oct 8
Form 4
+4.93%
29.67K
$88.88
-$1,842,482.40
631.19K
Feb 12
Form 4
—
0
—
—
0
Nov 16
Form 4
+1.43%
8.5K
$11.77
$99,990.02
601.52K
Jul 27
Form 4
-5.57%
-35.00K
$125.24
-$4,383,459.58
593.03K
Scheduled
Jul 5 - Jul 6
Form 4
-3.83%
-25.00K
$105.83
-$2,645,654.89
628.03K
Scheduled
May 16 - May 17
Form 4
+2.87%
18.2K
$76.85
-$855,438.54
653.03K
Feb 12
Form 4
—
0
—
—
0
Nov 17
Form 4
—
0
—
—
0
Apr 12
Form 4
+0.72%
4.52K
$29.82
-$67,918.57
634.82K
Feb 13
Form 4
—
0
—
—
0
Nov 18
Form 4
—
0
—
—
0
Sep 28
Form 4
—
0
—
—
0
Jul 20
Form 4
+7.07%
41.65K
$2.97
$123,848.07
630.3K
Jun 10
Form 4
+4.44%
25K
$2.97
$74,347.50
588.65K
May 10
Form 4
+3.41%
18.56K
$2.54
$47,198.77
563.65K
Mar 9
Form 4
—
0
—
—
0
Jan 9
Form 4
—
0
—
—
0
Nov 20
Form 4
+14.42%
68.7K
$1.53
$104,828.73
545.09K
Oct 23
Form 4
-3.05%
-15.00K
$33.37
-$500,520.67
476.39K
Scheduled
Mar 9
Form 4
-2.96%
-15.00K
$35.35
-$530,289.00
491.39K
Scheduled
Feb 20
Form 4
-2.88%
-15.00K
$50.43
-$756,462.50
506.39K
Scheduled
Jan 5
Form 4
+1.37%
7.05K
$0.73
$5,169.20
521.39K
Dec 12
Form 4
-2.83%
-15.00K
$45.39
-$680,815.20
514.34K
Scheduled
Dec 1
Form 4
—
0
—
—
0
Nov 20
Form 4
-2.76%
-15.00K
$42.52
-$637,811.86
529.34K
Scheduled
Nov 3
Form 4
—
0
—
—
0
Jan 10
Form 4
-2.68%
-15.00K
$39.17
-$587,542.24
544.34K
Scheduled
Apr 1
Form 4
-1.76%
-10.00K
$38.49
-$384,867.17
559.34K
Scheduled
Mar 10
Form 4
-1.01%
-5.80K
$38.10
-$220,974.81
569.34K
Scheduled
Feb 14
Form 4
+77.50%
251.12K
$0.73
$183,994.89
575.14K
Jan 10
Form 4
-1.76%
-5.80K
$28.05
-$162,698.51
324.02K
Scheduled
Jan 2
Form 4
—
0
—
—
0
Dec 8
Form 4
—
0
—
—
0
Dec 5
Form 3
—
0
—
—
0
No matching records found